Eton Expands Infantile Hemangioma Franchise with ASN-001 Acquisition
DEER PARK, Ill., August 5, 2026 Eton Pharmaceuticals has licensed the U.S. rights to ASN-001 (timolol topical gel) from...
Funding
Advertisement
Mironid Raises $46 Million to Advance ADPKD Therapy
Glasgow, Scotland, August 5, 2026 Mironid has successfully raised $46 million in a Series B financing round to accelerate...
Xeltis Raises €20.5M to Advance aXess and US Expansion
EINDHOVEN, The Netherlands, July 28, 2026 Xeltis has raised an additional €20.5 million in funding to accelerate the development...
Ambrosia Biosciences Raises $100M for GLP-1 Pipeline
BOULDER, Colo., USA — March 31, 2026 Ambrosia Biosciences Inc. has announced the successful completion of a $100 million...
Advertisement
